Xinxia Li
Impact in
-
- Hydrogels: synthesis, properties, applications
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 18
- Oncology 20
- Viral-associated cancers and disorders 8
- Vascular Tumors and Angiosarcomas 3
- CAR-T cell therapy research 3
- Co-authors
- Wenli Cui (13 shared papers)Wei Shao (1 shared paper)Kexin Huang (1 shared paper)Fang Wang (1 shared paper)Chaobo Huang (1 shared paper)Qian Zhang (1 shared paper)Encong Gong (2 shared papers)Michael A. McNutt (2 shared papers)
- Journals
- International Journal of Biological Macromolecules (2 papers)Frontiers in Immunology (2 papers)Human Pathology (2 papers)Journal of Clinical Pathology (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)
- Partner nations
- ChinaUnited StatesMongolia
In The Last Decade
Xinxia Li
49 papers receiving 454 citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 32
- Pathology and Forensic Medicine 103
- Biomaterials 70
- Oncology 118
- Pharmaceutical Science 24
Countries citing papers authored by Xinxia Li
This map shows the geographic impact of Xinxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxia Li more than expected).
Fields of papers citing papers by Xinxia Li
This network shows the impact of papers produced by Xinxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxia Li. The network helps show where Xinxia Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinxia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 81 | |
| 2 | 2007 | 44 | |
| 3 | 2007 | 27 | |
| 4 | 2015 | 22 | |
| 5 | Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-β1 and plasminogen activator inhibitor 1. | 2011 | 21 |
| 6 | 2023 | 20 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 16 | |
| 9 | 2019 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2020 | 11 | |
| 12 | 2014 | 10 | |
| 13 | 2019 | 10 | |
| 14 | 2014 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2020 | 9 | |
| 18 | 2017 | 8 | |
| 19 | 2023 | 8 | |
| 20 | [Diagnostic significance and clinical application of specific chimeric genes in soft tissue sarcomas by RT-PCR using paraffin-embedded tissues: a study of 103 specimens]. | 2004 | 7 |
About Xinxia Li
Xinxia Li is a scholar working on Pathology and Forensic Medicine, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 52 papers that have together received 460 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (18 papers), Viral-associated cancers and disorders (8 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer-related gene regulation (3 papers), Vascular Tumors and Angiosarcomas (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Molecular Medicine (32 citations), Pathology and Forensic Medicine (103 citations), Biomaterials (70 citations), Oncology (118 citations) and Pharmaceutical Science (24 citations). Xinxia Li has collaborated with scholars based in China, United States and Mongolia. Frequent co-authors include Wenli Cui, Wei Shao, Kexin Huang, Fang Wang, Chaobo Huang, Qian Zhang, Encong Gong, Michael A. McNutt, Virginia Anderson and Wei Zhang. Their work appears in journals such as International Journal of Biological Macromolecules, Frontiers in Immunology, Human Pathology, Journal of Clinical Pathology and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.